JPS6452719A - Heterocyclic sulfide - Google Patents

Heterocyclic sulfide

Info

Publication number
JPS6452719A
JPS6452719A JP63184752A JP18475288A JPS6452719A JP S6452719 A JPS6452719 A JP S6452719A JP 63184752 A JP63184752 A JP 63184752A JP 18475288 A JP18475288 A JP 18475288A JP S6452719 A JPS6452719 A JP S6452719A
Authority
JP
Japan
Prior art keywords
compound
substituted
cycloalkyl
alkyl
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP63184752A
Other languages
English (en)
Inventor
Shiyoineman Kaaruuhaintsu
Deyurukuhaimaa Buarutaa
Burumubatsuha Yurugen
Rimuberuto Mihiaeru
Shiyoruremaa Hansuuururitsuhi
Deikunaite Geeruharuto
Zetoratsueku Hansuuhaararuto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Publication of JPS6452719A publication Critical patent/JPS6452719A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/28—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/12—Oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/06—1,2,4-Triazines
    • C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
    • C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/36—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/44—Acylated amino or imino radicals
    • C07D277/46—Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D277/70—Sulfur atoms
    • C07D277/74—Sulfur atoms substituted by carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/12—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
    • C07D285/125—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Pyridine Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
JP63184752A 1985-03-12 1988-07-26 Heterocyclic sulfide Pending JPS6452719A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19853508665 DE3508665A1 (de) 1985-03-12 1985-03-12 Heterocyclische sulfide und ihre anwendung als immunmodulatoren

Publications (1)

Publication Number Publication Date
JPS6452719A true JPS6452719A (en) 1989-02-28

Family

ID=6264870

Family Applications (2)

Application Number Title Priority Date Filing Date
JP61051595A Granted JPS61212590A (ja) 1985-03-12 1986-03-11 複素環式スルフィド
JP63184752A Pending JPS6452719A (en) 1985-03-12 1988-07-26 Heterocyclic sulfide

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP61051595A Granted JPS61212590A (ja) 1985-03-12 1986-03-11 複素環式スルフィド

Country Status (21)

Country Link
US (1) US4762848A (ja)
EP (1) EP0194572B1 (ja)
JP (2) JPS61212590A (ja)
KR (1) KR940002255B1 (ja)
AR (1) AR247738A1 (ja)
AT (1) ATE70973T1 (ja)
AU (1) AU584993B2 (ja)
CA (1) CA1268769A (ja)
DE (2) DE3508665A1 (ja)
DK (1) DK165110C (ja)
ES (1) ES8801505A1 (ja)
FI (1) FI87203C (ja)
GR (1) GR860648B (ja)
HU (1) HU199441B (ja)
IE (1) IE58875B1 (ja)
IL (1) IL78090A (ja)
NO (1) NO167386C (ja)
NZ (1) NZ215425A (ja)
PH (1) PH24659A (ja)
PT (1) PT82167B (ja)
ZA (1) ZA861779B (ja)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2825659B2 (ja) * 1993-08-19 1998-11-18 フアイザー・インコーポレイテツド 抗ウィルス性チアゾール

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5047540A (en) * 1987-12-17 1991-09-10 Shionogi & Co., Ltd. Lipid derivatives
DE3816603A1 (de) * 1988-05-16 1989-11-30 Behringwerke Ag Verwendung des thiazol-derivates tiprotimod zur herstellung eines mittels zur therapie von virusinfektionen
DE3915094A1 (de) 1989-05-09 1991-01-10 Hoechst Ag Verfahren zur herstellung von 2-mercapto-4-methyl-1,3-thiazol-5-yl-essigsaeure und deren ester
JP2001517666A (ja) * 1997-09-23 2001-10-09 藤沢薬品工業株式会社 チアゾール誘導体
DE60228954D1 (en) * 2001-05-03 2008-10-30 Galileo Lab Inc Pyruvatderivate
TWI359810B (en) * 2004-11-04 2012-03-11 Mitsubishi Tanabe Pharma Corp Carboxylic acid derivative containing thiazole rin
WO2010051176A1 (en) 2008-10-29 2010-05-06 Merck Sharp & Dohme Corp. Novel cyclic benzimidazole derivatives useful anti-diabetic agents
WO2010051206A1 (en) 2008-10-31 2010-05-06 Merck Sharp & Dohme Corp. Novel cyclic benzimidazole derivatives useful anti-diabetic agents
CN116210105A (zh) * 2020-08-26 2023-06-02 路博润公司 2,5-二巯基-1,3,4-噻二唑（“dmtd”）金属盐衍生物

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3629473A (en) * 1965-10-21 1971-12-21 Ciba Geigy Corp Anti-inflammatory agents and compositions
US3671643A (en) * 1969-09-15 1972-06-20 Oreal Treatment of excessive sebaceous glands secretion with substituted cysteamine compounds
US3907822A (en) * 1973-06-11 1975-09-23 Squibb & Sons Inc Anti-inflammatory (2-benzimidazoylthio)alkylamidoximes
US3962237A (en) * 1974-02-11 1976-06-08 John Wyeth & Brother Limited 1 (h)-1,2,4-triazole derivatives
US4002624A (en) * 1976-01-26 1977-01-11 The Dow Chemical Company Substituted-3-thio-1,2,4-triazines
US4065584A (en) * 1974-09-30 1977-12-27 Victor Lafon Sulphur containing arylamine derivatives
US4251527A (en) * 1977-05-17 1981-02-17 Diamond Shamrock Corporation Pharmacologically active substituted 1,2,4-triazines
EP0093908A1 (de) * 1982-05-03 1983-11-16 Bayer Ag Heteroarylthiovinyl-Verbindungen, ein Verfahren zu ihrer Herstellung und ihre Verwendung als Schädlingsbekämpfungsmittel
JPS60105669A (ja) * 1983-10-11 1985-06-11 バイエル・アクチエンゲゼルシヤフト 新規な２−メルカプトチアゾ−ル誘導体、その製造方法及び薬剤としての使用

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR837278A (fr) * 1937-10-02 1939-02-07 Materiel Telephonique Dispositifs de sondage utilisant des ondes électro-magnétiques
US2776976A (en) * 1952-10-21 1957-01-08 Monsanto Chemicals Halogen substituted unsaturated thiazolylthioethers
US2886487A (en) * 1955-08-22 1959-05-12 Ortho Pharma Corp Quaternary ammonium salt and n-thiotrichloromethyl hydantoin vaginal composition
BE591151A (fr) * 1959-05-28 1960-11-23 Hoffmann La Roche Procédé pour la préparation de mono- et dihydrazino-triazines.
AT238200B (de) * 1962-03-27 1965-01-25 Degussa Verfahren zur Herstellung von neuen Pyridinderivaten
US3950542A (en) * 1967-02-21 1976-04-13 L'oreal Cysteamine derivatives for oral treatment of seborrhea
LU53029A1 (ja) * 1967-02-21 1968-08-27
US4139635A (en) * 1967-02-21 1979-02-13 L'oreal Cysteamine derivatives for oral treatment of seborrhea
US4035492A (en) * 1967-02-21 1977-07-12 L'oreal Oral treatment of seborrhea with cysteamine derivatives
FR6283M (ja) * 1967-03-07 1968-09-02
DE2129012A1 (de) * 1971-06-11 1973-01-04 Merck Patent Gmbh Azol-derivate
DE2165554A1 (de) * 1971-12-30 1973-07-05 Bayer Ag Verfahren zur herstellung von 1,2,4triazin-5-on-derivaten
DE2359922A1 (de) * 1973-12-01 1975-06-05 Hoechst Ag (1-alkyl-5-nitro-imidazolyl-2-alkyl)- heteroaryl-verbindungen und verfahren zu ihrer herstellung
US4107438A (en) * 1974-09-30 1978-08-15 Victor Lafon Cyclic phenylsulphinyl-amidine derivatives
US4022607A (en) * 1975-06-09 1977-05-10 Sandoz, Inc. Substituted oxazoles and thiazoles as herbicides
DE2533605A1 (de) * 1975-07-26 1977-02-03 Bayer Ag Antiparasitenmittel
SE7608611L (sv) * 1975-07-31 1977-02-01 Wellcome Found Sett att framstella en oralt intagbar farmaceutisk komposition
US4202901A (en) * 1976-03-04 1980-05-13 Ciba-Geigy Corporation 2-Pyridinecarbonitrile compounds
US4018923A (en) * 1976-03-10 1977-04-19 Eli Lilly And Company 5,6-Diaryl-1,2,4-triazines as topically-active anti-inflammatory agents
FR2368278A1 (fr) * 1976-10-25 1978-05-19 Fabre Sa Pierre Nouveaux medicaments antalgiques contenant des triazines 1-2-4
US4182769A (en) * 1977-02-09 1980-01-08 E. I. Du Pont De Nemours And Company Anti-inflammatory 1-substituted-4,5-diaryl-2-(substituted-thio) imidazoles and their corresponding sulfoxides and sulfones
AT367296B (de) * 1977-04-12 1982-06-25 Ciba Geigy Ag Verfahren zur kurativen und prophylaktischen bekaempfung von parasitaeren helminthen
CH634306A5 (de) * 1977-04-12 1983-01-31 Ciba Geigy Ag Benzimidazolderivate, verfahren zu ihrer herstellung und anthelmintische mittel enthaltend diese verbindungen als wirkstoffe.
GB1604085A (en) * 1977-05-17 1981-12-02 Diamond Shamrock Corp Pharmaceutical preparations containing 1,2,4-triazine derivatives
US4157392A (en) * 1977-05-17 1979-06-05 Diamond Shamrock Corporation Pharmacologically active substituted 1,2,4-triazines
US4396625A (en) * 1980-05-13 1983-08-02 Sumitomo Chemical Company, Limited Treatment of glaucoma or ocular hypertension and ophthalmic composition
US4379159A (en) * 1980-10-16 1983-04-05 E. I. Du Pont De Nemours & Company Antiinflammatory 2-substituted-thio-4,5-dihydro-4,5-diaryl-1H-imidazoles
US4451471A (en) * 1981-03-18 1984-05-29 Ciba-Geigy Corporation Certain 2,4,5-tri-substituted thiazoles, pharmaceutical compositions containing same and methods of using same
DE3118126A1 (de) * 1981-05-07 1982-12-02 Bayer Ag, 5090 Leverkusen Sulfenamide zur verwendung in arzneimitteln
ZA854550B (en) * 1984-06-18 1986-04-30 Smithkline Beckman Corp Leukotriene antagonists

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3629473A (en) * 1965-10-21 1971-12-21 Ciba Geigy Corp Anti-inflammatory agents and compositions
US3671643A (en) * 1969-09-15 1972-06-20 Oreal Treatment of excessive sebaceous glands secretion with substituted cysteamine compounds
US3907822A (en) * 1973-06-11 1975-09-23 Squibb & Sons Inc Anti-inflammatory (2-benzimidazoylthio)alkylamidoximes
US3962237A (en) * 1974-02-11 1976-06-08 John Wyeth & Brother Limited 1 (h)-1,2,4-triazole derivatives
US4065584A (en) * 1974-09-30 1977-12-27 Victor Lafon Sulphur containing arylamine derivatives
US4002624A (en) * 1976-01-26 1977-01-11 The Dow Chemical Company Substituted-3-thio-1,2,4-triazines
US4251527A (en) * 1977-05-17 1981-02-17 Diamond Shamrock Corporation Pharmacologically active substituted 1,2,4-triazines
EP0093908A1 (de) * 1982-05-03 1983-11-16 Bayer Ag Heteroarylthiovinyl-Verbindungen, ein Verfahren zu ihrer Herstellung und ihre Verwendung als Schädlingsbekämpfungsmittel
JPS60105669A (ja) * 1983-10-11 1985-06-11 バイエル・アクチエンゲゼルシヤフト 新規な２−メルカプトチアゾ−ル誘導体、その製造方法及び薬剤としての使用

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2825659B2 (ja) * 1993-08-19 1998-11-18 フアイザー・インコーポレイテツド 抗ウィルス性チアゾール

Also Published As

Publication number Publication date
HU199441B (en) 1990-02-28
GR860648B (en) 1986-07-11
KR940002255B1 (ko) 1994-03-19
DK165110C (da) 1993-03-01
NO167386C (no) 1991-10-30
IE58875B1 (en) 1993-12-01
JPS61212590A (ja) 1986-09-20
FI87203C (fi) 1992-12-10
AR247738A1 (es) 1995-03-31
DE3508665A1 (de) 1986-09-18
DK165110B (da) 1992-10-12
PH24659A (en) 1990-09-07
EP0194572B1 (de) 1992-01-02
DK108686D0 (da) 1986-03-10
ATE70973T1 (de) 1992-01-15
ES8801505A1 (es) 1988-01-16
AU5460686A (en) 1986-10-16
ES552841A0 (es) 1988-01-16
DE3683172D1 (de) 1992-02-13
EP0194572A1 (de) 1986-09-17
JPH0380792B2 (ja) 1991-12-26
NO167386B (no) 1991-07-22
US4762848A (en) 1988-08-09
IE860631L (en) 1986-09-12
IL78090A0 (en) 1986-07-31
NZ215425A (en) 1990-01-29
CA1268769A (en) 1990-05-08
ZA861779B (en) 1986-10-29
AU584993B2 (en) 1989-06-08
HUT44524A (en) 1988-03-28
FI860981A (fi) 1986-09-13
NO860907L (no) 1986-09-15
KR860007235A (ko) 1986-10-10
FI860981A0 (fi) 1986-03-10
PT82167A (de) 1986-04-01
PT82167B (pt) 1988-07-29
IL78090A (en) 1991-08-16
DK108686A (da) 1986-09-13
FI87203B (fi) 1992-08-31

Similar Documents

Publication Publication Date Title
IL93050A0 (en) Pyrazolopyridine derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
OA09039A (fr) Acides 3-alcenyl-1-azabicyclo(3.2.0)hep-2-ene-2carboxyliques
EP0275888A3 (en) Tricyclic benzimidazoles, process for their preparation and use as medicaments
GR3022631T3 (en) Trifluoromethylketone derivatives of peptides having HLE inhibiting activity, their preparation and pharmaceutical composition
JPS6452719A (en) Heterocyclic sulfide
TW340115B (en) Triazine derivatives and pharmaceutical composition for hepatitis the invention relates to triazine derivatives and pharmaceutical composition for hepatitis
ES8700673A1 (es) Un procedimiento para preparar derivados de acido griseolico
PH30210A (en) Oxazolidone derivative
NO164351C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-alkyl-l-fenyl-2-piperazinoalkylpyrazolin-3-on-forbindelser.
FI104071B1 (fi) Analogiamenetelmä terapeuttisesti käyttökelpoisten 2,5-dihydro-2,5-diokso-1H-bents[b]atsepiinijohdannaisten valmistamiseksi
JPS57154129A (en) Cardiotonic drug
MY110092A (en) Butyric acid derivatives
IL89324A0 (en) Therapeutic agents for the treatment of peptic ulcer disease containing xanthine derivatives
ZA928876B (en) Thiazole derivatives.
NO890996D0 (no) Fremgangsmaate for fremstilling av cefemforbindelser.
KR890012973A (ko) 이미다졸 유도체
GEP20002212B (en) Clavulanic Acid and Diamino Ether Derivatives, Di-Clavulanate Salt, Method for Its Production and Pharmaceutical Composition on Its Basis
IE902273L (en) Compositions of 5-phenyl-2-furan esters amides and ketones
KR890003372A (ko) 피리미도[2,1-b] 벤조티아졸 유도체로된 동맥경화 치료의약
HU913293D0 (en) Process for the production of pierazine derivatives and medical preparations containing them
ES8505653A1 (es) Procedimiento para preparar un n-alquil-(3 o 4)piperidinil benzoato
GB936783A (en) Improvements in and relating to n-heterocyclic compounds
JPS5569569A (en) Carcinostatic
SE8802997D0 (sv) Aminderivat och dess salt, forfarande for framstellning derav och medel mot sar innehallande desamma
JPS6452720A (en) Nootropic